Craig Jonathan Gulliford Buys 8,036 Shares of Creo Medical Group (LON:CREO) Stock

Creo Medical Group PLC (LON:CREO) insider Craig Jonathan Gulliford purchased 8,036 shares of the business’s stock in a transaction dated Tuesday, January 13th. The stock was purchased at an average price of GBX 11 per share, for a total transaction of £883.96.

Creo Medical Group Stock Up 0.5%

LON:CREO opened at GBX 11.05 on Wednesday. The stock has a 50-day simple moving average of GBX 10.38 and a 200 day simple moving average of GBX 11.76. Creo Medical Group PLC has a 52-week low of GBX 9.22 and a 52-week high of GBX 22.50. The company has a market cap of £45.58 million, a PE ratio of -11.05 and a beta of 0.86. The company has a debt-to-equity ratio of 29.96, a quick ratio of 2.19 and a current ratio of 3.24.

About Creo Medical Group

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.

The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive. The Group has developed the CROMA powered by Kamaptive full-spectrum adaptive technology to optimise surgical capability and patient outcomes.